financetom
Business
financetom
/
Business
/
Buckle Insider Sold Shares Worth $879,416, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Buckle Insider Sold Shares Worth $879,416, According to a Recent SEC Filing
Oct 23, 2024 10:31 PM

03:15 PM EDT, 10/23/2024 (MT Newswires) -- Dennis H Nelson, Director, President & CEO, on October 22, 2024, sold 20,453 shares in Buckle (BKE) for $879,416. Following the Form 4 filing with the SEC, Nelson has control over a total of 2,249,193 shares of the company, with 324,000 shares held directly and 1,925,193 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885245/000088524524000099/xslF345X05/wk-form4_1729710197.xml

Price: 42.59, Change: -0.34, Percent Change: -0.79

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tempur Sealy International Faces 'Formidable' Rival After Ashley Home's Acquisition of Resident Homes, UBS Says
Tempur Sealy International Faces 'Formidable' Rival After Ashley Home's Acquisition of Resident Homes, UBS Says
Mar 7, 2024
03:35 PM EST, 03/07/2024 (MT Newswires) -- Tempur Sealy International ( TPX ) faces a formidable bedding rival after Ashley Home's acquisition of Resident Homes, UBS Securities said Wednesday in a note. The combined company enhances the multi-branded retail presence and can drive significant mindshare and consumer interest in the future, UBS said. Still, Tempur remains well positioned to defend...
US FDA approves expanded use of BeiGene's blood cancer drug
US FDA approves expanded use of BeiGene's blood cancer drug
Mar 7, 2024
March 7 (Reuters) - The U.S. Food and Drug Administration has granted accelerated approval for the expanded use of BeiGene's ( BGNE ) combination drug to treat certain patients with a type of blood cancer, the health regulator said on Thursday. ...
RBC boosts CEO's compensation, pays P&C head C$1.25 million for closing HSBC Canada deal
RBC boosts CEO's compensation, pays P&C head C$1.25 million for closing HSBC Canada deal
Mar 7, 2024
TORONTO, March 7 (Reuters) - Royal Bank of Canada ( RY ) set a total compensation target of C$17 million ($12.6 million) for CEO Dave McKay for 2024, about 12% more than last year, the country's biggest lender disclosed in a circular on Thursday. RBC said it also paid the head of its personal and commercial banking segment Neil McLaughlin...
Palantir CEO Alex Karp At AIPCon: 'Your Enterprise Reimagined, And No Steak Dinner'
Palantir CEO Alex Karp At AIPCon: 'Your Enterprise Reimagined, And No Steak Dinner'
Mar 7, 2024
Palantir Technologies, Inc. ( PLTR ) hosted its annual AIPCon on Thursday with more than 60 customers showcasing real-world use cases for the company’s Artificial Intelligence Platform (AIP). What Happened: Palantir ( PLTR ) CEO Alex Karp introduced the event with opening remarks that highlighted the value of AIP and AIP Bootcamps.  The whole reason for the bootcamp is to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved